p53 Inhibits Adriamycin-Induced Down-Regulation of Cyclin D1 Expression in Human Cancer Cells

By Shao J.   Teraishi F.   Katsuda K.   Tanaka N.   Fujiwara T.  

Biochemical and Biophysical Research Communications, Vol. 290, Iss. 3, 2002-01 ,pp. : 1101-1107

Elsevier

Access to resources Recommend Favorite

Overexpression of DAN Causes a Growth Suppression in p53-Deficient SAOS-2 Cells

By Hanaoka E.   Ozaki T.   Nakamura Y.   Moriya H.   Nakagawara A.   Sakiyama S.  

Biochemical and Biophysical Research Communications, Vol. 278, Iss. 1, 2000-11 ,pp. : 20-26

Elsevier

Access to resources Recommend Favorite

Binding of Wild-Type P53 by Topoisomerase II and Overexpression of Topoisomerase II in Human Hepatocellular Carcinoma

By Yuwen H.   Hsia C.C.   Nakashima Y.   Evangelista A.   Tabor E.  

Biochemical and Biophysical Research Communications, Vol. 234, Iss. 1, 1997-05 ,pp. : 194-197

Elsevier

Access to resources Recommend Favorite

Wild-type p53 reduces radiation hypermutability in p53-mutated human lymphoblast cells

By Zhang Qinming   Liu Yunfeng   Zhou Junqing   Chen Weihong   Zhang Ying   Liber Howard L.  

Mutagenesis, Vol. 22, Iss. 5, 2007-09 ,pp. : 329-334

Oxford University Press

Access to resources Recommend Favorite

Mitochondrial impairment in p53-deficient human cancer cells

By Zhou S.   Kachhap S.   Singh K.K.  

Mutagenesis, Vol. 18, Iss. 3, 2003-05 ,pp. : 287-292

Oxford University Press

Access to resources Recommend Favorite